Summary
TB-500 is a synthetic version of the naturally occurring 43-amino-acid peptide Thymosin Beta-4 (Tβ4). Scientific literature has examined it in relation to actin regulation, vascular development, angiogenesis, and tissue-remodeling pathways.
Overview
TB-500 reproduces the sequence and activity of endogenous Thymosin Beta-4, one of the most abundant intracellular proteins in vertebrate tissues. Its primary biochemical role is as a G-actin-sequestering molecule that regulates actin polymerization, with downstream consequences for cell motility and tissue remodeling.
Research Background
Thymosin Beta-4 was originally isolated from calf thymus by Allan Goldstein and colleagues in the early 1980s. Subsequent decades of work by Goldstein, Hannappel, Sosne, Kleinman, and colleagues established its role in actin regulation, angiogenesis, and corneal and cardiac repair models.
Mechanisms Studied
Mechanistic interest centers on G-actin sequestration through the canonical Tβ4-actin binding domain, regulation of the actin cytoskeleton, and downstream effects on cell migration, angiogenesis, and tissue remodeling. Vascular development and corneal repair models are common settings for TB-500 / Tβ4 research.
Published Research Summary
Goldstein et al. (2012) review Thymosin Beta-4 as a multi-functional regenerative peptide across the published literature. Sosne et al. (2002) characterized Tβ4 in corneal repair models. Crockford et al. (2010) reviewed the broader development trajectory of Tβ4 in preclinical research.
Quality & Verification
For research compounds, lot-level documentation is the starting point for any analytical work. Researchers commonly examine batch-specific Certificates of Analysis, reversed-phase HPLC purity readouts, mass-spectrometry confirmation of molecular weight, and lot identification to evaluate compound identity, purity, and consistency before downstream experiments.
References & Published Research
- Goldstein AL, Hannappel E, Sosne G, Kleinman HK — Thymosin β4: a multi-functional regenerative peptide. Basic properties and clinical applications
- Sosne G, Szliter EA, Barrett R, Kernacki KA, Kleinman H, Hazlett LD — Thymosin beta 4 promotes corneal wound healing and decreases inflammation in vivo following alkali injury
- Crockford D et al. — Thymosin beta4: structure, function, and biological properties supporting current and future clinical applications